Advertisement

Topics

Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Pipeline Review, H1 2019 [Report Updated: 23042019] Prices from USD $3500

14:04 EDT 14 Jun 2019 | BioPortfolio Report Blog

Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Pipeline Review, H1 2019


Summary


According to the recently published report 'Survival Motor Neuron Protein Pipeline Review, H1 2019'; Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 pipeline Target constitutes close to 18 molecules. Out of which approximately 11 molecules are developed by companies and remaining by the universities/institutes.


Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Survival of motor neuron or survival motor neuron SMN is a protein encoded by the SMN1 and SMN2 genes. The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins snRNPs. They play an important role in the splicing of cellular premRNAs. They ensure the correct splicing of U12 introncontaining genes that is important for normal motor and proprioceptive neurons development. They are required for resolving RNADNA hybrids created by RNA polymerase II. They play a role in the metabolism of small nucleolar ribonucleoprotein.


The report 'Survival Motor Neuron Protein Pipeline Review, H1 2019' outlays comprehensive information on the Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.


It also reviews key players involved in Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in PreRegistration, Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 1, 1 and 7 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 5 and 2 molecules, respectively. Report covers products from therapy areas Central Nervous System and Respiratory which include indications Spinal Muscular Atrophy SMA and Cystic Fibrosis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2

The report reviews Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 targeted therapeutics and enlists all their major and minor projects

The report assesses Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Pipeline Review, H1 2019 [Report Updated: 23042019] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Pipeline Review, H1 2019 [Report Updated: 23042019] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...